TotalMarketCap

Ovid Therapeutics

OVIDNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$503.868 M

$2.58 -5.84%

Close of 6 Nov 2026

As of 6 Nov 2026, Ovid Therapeutics (OVID) has a market capitalization of $503.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$7.25M

#3196 by revenue

Earnings

-$17.4M

Loss-making

Shares outstanding

195,297,857

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #186Faeth TherapeuticsFTH$509.9M
  2. #187Puma BiotechnologyPBYI$505.4M
  3. #188Ovid TherapeuticsOVID$503.9M
  4. #189Capricor TherapeuticsCAPR$499.4M
  5. #190DiaMedica TherapeuticsDMAC$488.6M

What if Ovid Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$144,583.63

Per share 56,040× higher

Bitcoin $1.53T

$7,823.17

Per share 3,032× higher

Apple $5.02T

$25,682.73

Per share 9,955× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Ovid Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.